Dr. Wafaa El-Sadr, director of ICAP and University Professor of Epidemiology and Medicine at Columbia University Mailman School of Public Health, will give a plenary talk on October 13th entitled “Bringing precision to the global HIV response” at the 12th Netherlands Conference on human immunodeficiency virus (HIV) Pathogenesis, Epidemiology, Prevention and Treatment (NCHIV2019).
The conference brings together biomedical scientists, clinicians, and epidemiologists in . human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) to share knowledge on the current status and new developments in the understanding of HIV pathogenesis, epidemiology, prevention, and treatment.
Dr. El-Sadr, who also holds the Dr. Mathilde Krim-amFAR Chair in Global Health at Columbia Mailman School, is an international expert in epidemiology and research on the prevention and management of HIV, tuberculosis, and other infectious diseases. She leads ICAP’s portfolio of projects in more than 30 countries; under her leadership, ICAP has become a global leader in health systems strengthening and addressing major public health challenges including maternal and child health, women’s health, and non-communicable diseases, among other health threats.
Dr. El-Sadr is a principal investigator of the National Institutes of Health (NIH)-funded HIV Prevention Trials Network (HPTN), which seeks to prevent HIV transmission globally. In 2008, she was named a John D. and Catherine T. MacArthur Foundation Fellow. She is widely published in scientific literature, and serves as a model of service and dedication for students and colleagues at Columbia and beyond.
Dr. El-Sadr was interviewed ahead of the Conference on her work in the U.S. and sub-Saharan Africa and her passion for working with the community of people living with HIV.Tags: Friday Letter Submission, Publish on November 01